We are live on ! Find out more
VTRS icon

Viatris

1,011 hedge funds and large institutions have $9.34B invested in Viatris in 2022 Q2 according to their latest regulatory filings, with 97 funds opening new positions, 323 increasing their positions, 418 reducing their positions, and 92 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more funds holding in top 10

Funds holding in top 10: 1013 (+3)

23% more call options, than puts

Call options by funds: $103M | Put options by funds: $83.7M

5% more first-time investments, than exits

New positions opened: 97 | Existing positions closed: 92

0.61% more ownership

Funds ownership: 73.44%74.04% (+0.61%)

1% less capital invested

Capital invested by funds: $9.39B → $9.34B (-$56.3M)

1% less funds holding

Funds holding: 1,0231,011 (-12)

23% less repeat investments, than reductions

Existing positions increased: 323 | Existing positions reduced: 418

Holders
1,011
Holders Change
-12
Holders Change %
-1.17%
% of All Funds
17.03%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.22%
New
97
Increased
323
Reduced
418
Closed
92
Calls
$103M
Puts
$83.7M
Net Calls
+$19.5M
Net Calls Change
+$19.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.52B +$76.6M +6,987,626 +5%
BlackRock
2
BlackRock
New York
$979M +$57.4M +5,240,282 +6%
State Street
3
State Street
Massachusetts
$608M +$16.3M +1,482,983 +3%
DSA
4
Davis Selected Advisers
Arizona
$581M -$13.2M -1,200,143 -2%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$578M
Geode Capital Management
6
Geode Capital Management
Massachusetts
$260M +$4.54M +414,189 +2%
CCM
7
Camber Capital Management
Massachusetts
$241M
DM
8
Deerfield Management
New York
$216M
LCM
9
Laurion Capital Management
New York
$193M -$120M -10,970,594 -37%
Schroder Investment Management Group
10
Schroder Investment Management Group
United Kingdom
$173M +$2.42M +220,381 +1%
Invesco
11
Invesco
Georgia
$147M -$9.81M -894,610 -6%
Arrowstreet Capital
12
Arrowstreet Capital
Massachusetts
$131M +$100M +9,134,931 +274%
Northern Trust
13
Northern Trust
Illinois
$130M -$291K -26,582 -0.2%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$119M +$3.62M +330,193 +3%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$113M -$7.37M -672,667 -6%
Morgan Stanley
16
Morgan Stanley
New York
$111M +$49.6M +4,522,533 +74%
AQR Capital Management
17
AQR Capital Management
Connecticut
$106M +$67.9M +6,197,249 +159%
Norges Bank
18
Norges Bank
Norway
$101M +$18M +1,645,673 +20%
Charles Schwab
19
Charles Schwab
California
$101M +$2.46M +224,766 +2%
Legal & General Group
20
Legal & General Group
United Kingdom
$91.8M +$4.31M +393,590 +5%
Bank of America
21
Bank of America
North Carolina
$90.8M -$31.4M -2,862,704 -25%
Pacer Advisors
22
Pacer Advisors
Pennsylvania
$87.3M +$38.6M +3,516,548 +73%
Goldman Sachs
23
Goldman Sachs
New York
$78.2M -$23.2M -2,120,633 -22%
Fidelity Investments
24
Fidelity Investments
Massachusetts
$75.7M +$9.94M +906,728 +14%
Two Sigma Advisers
25
Two Sigma Advisers
New York
$64.4M +$57M +5,201,500 +547%

VTRS Hedge Fund Activity: Q2 2022 in Review

1,011 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q2 2022, worth a combined $9.34B — down 0.6% from $9.39B a quarter earlier.

Buyers outnumbered sellers: 97 funds opened new VTRS positions and 92 closed out — a net gain of 5 holders — while 323 added to existing stakes and 418 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $100M. The largest seller was Macquarie Group, cutting an estimated $241M.

  • 1,011 institutional investors held Viatris (VTRS) as of Q2 2022, down from 1,023 in Q1 2022.
  • Funds reported $9.34B of Viatris stock for Q2 2022, down 0.6% quarter-over-quarter.
  • 97 funds opened new Viatris positions in Q2 2022 and 92 closed out, a net change of +5 holders.
  • The largest Viatris buyer in Q2 2022 was Arrowstreet Capital, an estimated $100M added.
  • The largest Viatris seller in Q2 2022 was Macquarie Group, an estimated $241M sold.

Based on aggregated 13F filings for Q2 2022.